secwatch.observer — SEC 8-K summary
======================================

Issuer:     Streamex Corp. (STEX)
CIK:        0001530766
Form:       8-K/A
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001641172-25-020308
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioSig amends 8-K to provide Streamex business overview, risk factors, and pro forma financials
--------------------------------------------------------------------------------

- Streamex generated ~$200,000 revenue in Q1 2025; platform still under development with no tokenized assets launched.
- Streamex to tokenize real-world assets starting with gold; competes with Pax Gold ($810M cap) and Securitize ($4B+ tokenized).
- BioSig now operates two segments: healthcare (PURE EP/ViralClear) and tokenized finance through Streamex.
- Streamex holds minority interest in Canadian Exempt Market Dealer license; tokens likely classified as securities.
- Pro forma combined financials filed for periods ended March 31, 2025 and December 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530766/000164117225020308/0001641172-25-020308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530766/000164117225020308/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer